Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD (I2PETPG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02874820
Recruitment Status : Terminated (Patient recruitment issues.)
First Posted : August 22, 2016
Last Update Posted : August 27, 2020
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Imperial College London

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 2017
Actual Study Completion Date : July 2017